EUCTR2014-003498-41-AT进行中（未招募）不适用
Effects of dalfampridine on mobility in the context of daily life - Fampridine Study in Activities of Daily Living
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients over 18 years with multiple sclerosis and an EDSS between 4 and 7, suffering from gait disturbance will be included. Only patients who have been identified as responders during a previous named patient programme and were refused to get reimbursement by the public health care system in Austria will be included.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 51
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Exclusion criteria will be a treatment with Fampridine less then 6 weeks before the start of the study, previously identified non-response to Fampridine and an age below 18 years.
研究者
相似试验
招募中
3 期
The effect of Dalfampridine in HTLV-1 patientsHTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients.Tropical spastic paraplegiaG04.1IRCT20180618040127N4Mashhad University of Medical Sciences40
已完成
不适用
Dalfampridine and Gait in Spinocerebellar AtaxiasSpinocerebellar Ataxias Type 1Spinocerebellar Ataxias Type 2Spinocerebellar Ataxias Type 3Spinocerebellar Ataxias Type 6NCT01811706University of Florida20
招募中
不适用
Dalfampridine in Egyptian Patients With Multiple SclerosisMultiple SclerosisNCT05730738Ain Shams University100
招募中
3 期
Dalfampridine in improving spasticity in patients with severe brain traumaSevere traumatic brain injury.Diffuse traumatic brain injuryS06.2IRCT20221108056446N2Esfahan University of Medical Sciences80
已完成
2 期
Effect of Dalfampridine (4-AP) on Genioglossus Muscle Activity in Healthy AdultsSleep Apnea, ObstructiveNCT02656160Brigham and Women's Hospital13